Edition:
United States

Corium International Inc (CORI.OQ)

CORI.OQ on NASDAQ Stock Exchange Global Market

10.99USD
15 Dec 2017
Change (% chg)

$-0.30 (-2.66%)
Prev Close
$11.29
Open
$11.28
Day's High
$11.28
Day's Low
$10.33
Volume
749,785
Avg. Vol
65,841
52-wk High
$12.30
52-wk Low
$2.73

Chart for

About

Corium International, Inc. is a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty pharmaceutical products. As of September 30, 2016, the Company had multiple programs in preclinical and clinical development focused primarily on the treatment of neurological... (more)

Overall

Beta: 1.25
Market Cap(Mil.): $392.81
Shares Outstanding(Mil.): 35.74
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 35.70
ROE: -- 16.55 15.40

BRIEF-Corium reports Q4 loss per share $0.36

* Corium reports fourth quarter and fiscal year 2017 financial results and corporate highlights

Nov 16 2017

BRIEF-Corium Q3 loss per share $0.43

* Corium reports recent corporate highlights and financial results for third quarter fiscal 2017

Aug 03 2017

BRIEF-Corium presents clinical results from pilot bioequivalence study

* Corium presents clinical results from pilot bioequivalence study of corplex donepezil transdermal system at Alzheimer's Association International Conference 2017

Jul 18 2017

Earnings vs. Estimates